Skip to main content
Akebia, Keryx Bio announce successful completion of merger

Akebia Therapeutics and Keryx Biopharmaceuticals have completed the merger of their companies and are doing business under Akebia Therapeutics. Akebia is still traded on the Nasdaq Capital Market, while Keryx has been delisted, and its shareholders will receive shares in the merged company.

Full Story: